NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 261 filers reported holding NATERA INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,797,421 | -47.8% | 72,005 | -55.9% | 0.16% | -36.5% |
| Q1 2024 | $14,933,680 | +67.1% | 163,281 | +14.4% | 0.26% | +65.6% |
| Q4 2023 | $8,938,728 | +0.5% | 142,700 | -29.0% | 0.15% | -22.2% |
| Q3 2023 | $8,898,675 | +11.8% | 201,100 | +22.9% | 0.20% | +38.5% |
| Q2 2023 | $7,960,776 | -33.0% | 163,600 | -23.6% | 0.14% | -21.0% |
| Q1 2023 | $11,886,832 | +115.8% | 214,100 | +56.2% | 0.18% | +166.2% |
| Q4 2022 | $5,507,307 | -47.9% | 137,100 | -43.2% | 0.07% | -46.5% |
| Q3 2022 | $10,578,000 | +11.3% | 241,400 | -10.0% | 0.13% | +14.4% |
| Q2 2022 | $9,501,000 | +99.9% | 268,100 | +426.7% | 0.11% | +122.0% |
| Q4 2021 | $4,754,000 | -23.5% | 50,900 | -72.4% | 0.05% | -58.7% |
| Q4 2019 | $6,216,000 | +114.1% | 184,500 | -31.0% | 0.12% | +75.4% |
| Q2 2017 | $2,903,000 | +8.7% | 267,281 | +17.2% | 0.07% | -5.5% |
| Q4 2016 | $2,671,000 | – | 228,060 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
| Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
| Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
| Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
| Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
| Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
| Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
| Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
| PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
| PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |